Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

VWXY20_ACCIDENTAL_POISO_EXPOS_ORGANIC_SOLVE_HALOGENA_HYDROCA_THEIR_VAPOU

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X46 Cause of death: ICD-10 — X46 2 out of 7 registries used, show all original rules.	90
4. Check minimum number of events None	90
5. Include endpoints None	90
6. Filter based on genotype QC (FinnGen only)	86

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X40-X49

NAME	VWXY20_ACCIDENTAL_POISO_EXPOS_ORGANIC_SOLVE_HALOGENA_HYDROCA_THEIR_VAPOU
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X46
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X46
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	86	33	53
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	46.53	41.32	49.78

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
90: Matched controls
900

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X46

ICD-10 Finland

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

+∞

129.6

T36

ICD-10 Finland

Poisoning by systemic antibiotics

15.7

11.8

N05AH04

ATC

quetiapine; oral

4.9

11.5

104

T52.9

ICD-10 Finland

Toxic effect: Organic solvent, unspecified

+∞

10.6

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

17.4

10.5

N06AB04

ATC

citalopram; systemic

4.3

9.0

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.5

8.3

T52.8

ICD-10 Finland

Toxic effect: Other organic solvents

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016879) Cocaine [Presence] in Urine

4.88

6.90

5.9

1.3

—

(3028300) Cannabinoids [Presence] in Urine

4.42

6.15

5.9

1.4

—

(3027008) Opiates [Presence] in Urine

4.42

6.15

5.9

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

4.32

5.97

5.9

1.4

—

(3011288) Drugs identified in Urine by Screen method

5.72

5.20

6.7

1.9

—

(3027944) Amphetamines [Presence] in Urine

4.01

5.17

6.3

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

5.24

5.16

2.8

1.4

—

(3023368) Bacteria identified in Blood by Culture

182

2.51

4.10

4.9

4.5

—

(3028707) Methadone [Presence] in Urine by Screen method

6.12

3.76

5.3

1.6

—

(3019150) Specific gravity of Urine by Refractometry

146

2.46

3.58

6.6

3.4

1.01

1.02

kg/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

3.41

2.15

1.1

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

4.20

2.07

1.3

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

3.94

1.97

1.3

1.4

4.37

3.69

mmol/l

—

(3003396) Base excess in Arterial blood by calculation

2.33

1.94

4.8

6.6

3.32

1.12

mmol/l

1.39

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2.33

1.94

4.8

6.3

5.22

5.12

kpa

0.21

(4200892) Spirometry reversibility

2.59

1.94

1.1

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.93

1.84

6.9

7.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.13

1.78

2.1

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.24

1.69

1.5

2.2

0.20

0.24

g/l

0.72

(3023511) Choriogonadotropin [Units/volume] in Urine

3.71

1.64

1.8

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

102

1.96

1.59

1.9

2.4

—

(40768443) Skin Pathology biopsy report

2.85

1.46

1.3

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.00

1.39

1.5

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

115

1.83

1.39

1.9

2.6

—

(3019060) Gas panel - Arterial blood

2.27

1.38

2.6

3.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.05

1.37

1.4

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.05

1.37

1.4

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.10

1.28

1.0

1.6

—

(40768797) Stomach Pathology biopsy report

1.87

1.24

1.0

1.3

—

(3015736) pH of Urine

268

1.57

1.23

5.2

3.2

—

5.63

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

1.18

0.0

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.36

1.13

1.6

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2.46

1.10

2.4

10.14

10.20

mg/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

265

1.52

1.09

3.4

3.7

24.77

43.13

ng/l

0.68

179

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.83

1.05

1.5

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

160

1.59

1.02

1.5

1.3

0.70

1.18

u/ml

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

143

1.61

1.02

1.8

1.9

3.03

3.38

mg/l

0.25

125

(3008898) HLA-B27 [Presence]

0.00

0.97

0.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

1.75

0.94

1.4

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

148

1.55

0.88

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

332

1.43

0.88

5.3

6.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1.81

0.85

1.0

1.2

—

17.36

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

0.48

0.84

1.4

1.3

—

5.20

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

182

0.61

0.82

3.2

2.8

0.49

0.80

ug/l

—

110

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

326

1.41

0.81

3.3

2.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.73

0.81

1.4

1.2

—

(36304419) Bacteria [Presence] in Urine

187

1.47

0.80

2.9

2.6

—

(3049717) Cytology report of Urine Cyto stain

2.24

0.77

2.2

2.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.24

0.77

1.4

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.64

0.77

5.2

6.3

102.69

104.71

mmol/l

0.58

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

245

1.40

0.74

1.8

97.91

91.85

pmol/l

0.29

124

(21494755) Public health laboratory ask at order entry panel

116

0.57

0.74

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

2.06

0.74

1.4

3.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.68

0.72

3.3

3.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

735

1.61

0.71

18.3

12.4

21.38

21.61

mg/l

0.03

574

(3019832) Treponema pallidum Ab [Presence] in Serum

104

1.53

0.68

1.5

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.83

0.67

4.8

2.7

39.20

48.77

u/l

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

113

1.51

0.67

3.8

3.0

1100.91

31.18

ng/l

0.46

(3013650) Neutrophils [#/volume] in Blood by Automated count

415

1.34

0.64

8.9

10.7

4.08

4.07

e9/l

0.01

364

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

270

1.35

0.63

4.3

3.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.70

0.62

2.2

1.7

42.20

39.40

nmol/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.61

0.0

1.8

—

90.45

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.61

0.0

3.0

—

0.20

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

107

1.48

0.60

3.1

2.6

1.25

1.78

e6/l

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

244

1.34

0.59

2.6

2.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.55

0.56

1.4

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

109

1.45

0.55

3.1

2.5

1.48

0.75

e6/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

154

1.38

0.55

3.7

3.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

344

1.29

0.53

6.3

4.4

0.00

estimate

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.53

0.52

1.0

2.9

—

(3035350) Ketones [Presence] in Urine by Test strip

345

1.29

0.51

4.6

3.3

0.00

0.01

estimate

—

(3022621) pH of Urine by Test strip

1.50

0.48

7.9

2.0

—

(3003694) ABO and Rh group [Type] in Blood

195

1.31

0.47

1.4

1.5

—

(3025159) Blasts/100 leukocytes in Blood

1.43

0.46

2.3

5.5

—

0.44

—

(3044640) Blood type and Crossmatch panel - Blood

224

1.29

0.46

2.6

2.4

—

(3000991) Gas panel - Venous blood

1.47

0.44

7.0

8.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.47

0.44

2.6

2.7

—

(3009261) Glucose [Presence] in Urine by Test strip

351

1.25

0.43

4.7

3.3

0.00

estimate

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

2.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

2.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

249.14

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.41

0.0

1.3

—

(3019225) pH of Specimen

1.37

0.41

3.6

4.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

1.9

—

178.63

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.41

0.0

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.41

0.0

3.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.41

0.0

3.4

—

56.76

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.41

0.0

2.5

—

4.18

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

190

1.28

0.40

2.3

2.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.40

0.40

3.0

1.8

401.33

384.00

nmol/l

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.41

0.39

1.6

3.0

0.27

0.23

e6/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

692

1.29

0.36

3.8

4.0

5.90

5.87

mmol/l

0.09

630

(3002582) Erythrocytes [#/volume] in Urine

212

1.25

0.35

2.9

2.8

12.54

21.85

e6/l

0.64

170

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

693

1.28

0.35

12.3

11.7

88.13

86.20

ml/min/173m2

0.26

568

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

110

1.32

0.34

1.5

1.9

—

(40758558) Short blood count panel - Blood

176

1.25

0.33

5.2

7.6

—

(3018095) Leukocytes [#/volume] in Urine

243

1.22

0.32

3.8

3.3

225.73

39.29

e6/l

0.55

175

(3021440) Promyelocytes/100 leukocytes in Blood

1.37

0.32

2.3

5.3

—

0.32

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

727

1.29

0.32

19.2

14.1

139.22

139.76

mmol/l

1.19

700

(3048689) Calprotectin [Mass/mass] in Stool

1.33

0.32

1.4

2.3

183.57

152.19

ug/g

—

(3017732) Neutrophils [#/volume] in Blood

1.35

0.32

2.9

1.9

4.55

9.74

e9/l

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

106

0.73

0.31

3.3

3.0

2.45

2.44

mmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.36

0.29

1.1

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

729

1.27

0.29

19.2

14.3

3.98

4.00

mmol/l

0.15

703

(3037467) Urinalysis macro (dipstick) panel - Urine

483

1.18

0.28

5.5

3.8

—

(3022145) Colonoscopy Study observation

1.28

0.27

1.1

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

190

1.21

0.26

3.0

2.8

0.67

0.39

e6/l

0.37

146

(3042936) Bacteria identified in Isolate by Culture

106

1.26

0.25

2.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

163

1.21

0.24

2.9

2.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.33

0.23

9.2

5.2

26.18

24.11

mmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.33

0.23

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

528

1.16

0.23

4.4

3.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1.20

0.22

2.0

6.3

65.20

89.55

ng/l

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

6.83

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.21

0.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.4

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.5

—

3.40

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.9

—

4.27

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.30

0.21

1.3

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

233

1.16

0.21

3.2

2.5

65.85

55.87

u/l

0.60

218

(40761511) CBC panel - Blood by Automated count

778

1.25

0.20

16.9

11.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.24

0.20

2.3

2.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.19

0.20

2.3

5.4

—

0.48

—

(36660697) Celiac disease serology panel - Serum

1.25

0.19

1.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

120

1.20

0.17

1.7

—

(1761868) Lipid panel - Serum or Plasma

305

0.88

0.17

2.3

2.6

—

(3026361) Erythrocytes [#/volume] in Blood

829

0.88

0.16

25.2

18.5

4.52

4.59

e12/l

0.66

809

(3000963) Hemoglobin [Mass/volume] in Blood

829

0.88

0.16

25.3

18.6

135.89

138.71

g/l

1.00

816

(3024731) MCV [Entitic volume]

829

0.88

0.16

25.3

18.5

90.45

90.77

0.26

816

(3035941) MCH [Entitic mass]

829

0.88

0.16

25.2

18.4

30.28

30.35

0.15

816

(3007461) Platelets [#/volume] in Blood

828

0.89

0.16

25.5

18.6

262.95

245.29

e9/l

1.49

810

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.75

0.16

13.2

8.5

—

(3026008) Bacteria identified in Urine by Culture

179

1.15

0.16

3.4

2.7

—

(3000492) Spirometry study

1.12

0.15

1.3

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.21

0.15

2.2

7.4

1.20

1.02

mmol/l

0.70

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

170

1.15

0.15

1.6

1.7

1.78

1.45

mmol/l

0.83

144

(3012516) Albumin [Mass/volume] in Urine

200

1.13

0.14

2.3

3.3

3601.84

113.23

mg/l

0.46

123

(3041096) Erythrocytes [Presence] in Urine by Automated

210

1.13

0.14

4.5

2.7

—

(40768804) Tissue Pathology biopsy report

271

0.89

0.13

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

105

1.16

0.11

2.2

3.9

0.79

0.82

mmol/l

0.49

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.18

0.11

1.6

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

135

1.13

0.10

1.3

1.6

0.96

1.39

mg/l

—

107

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.17

0.10

1.4

2.2

—

(3025941) Bacteria identified in Stool by Culture

1.17

0.10

1.4

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.80

0.08

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

826

0.92

0.08

25.7

18.6

38.36

41.12

1.64

783

(3021589) Normoblasts [#/volume] in Blood

306

1.07

0.07

7.8

9.8

0.00

e9/l

0.50

249

(3044889) 12 lead EKG panel

476

1.06

0.06

3.8

3.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

161

1.07

0.03

2.0

3.0

312.12

8219.06

umol/l

0.98

141

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.10

0.03

1.2

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.10

0.03

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

158

0.94

0.02

2.1

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

238

0.95

0.02

4.9

4.4

23.33

22.54

—

101

(3022217) INR in Platelet poor plasma by Coagulation assay

302

1.04

0.02

10.1

10.5

1.16

inr

—

(3029937) Albumin [Presence] in Urine by Test strip

186

0.96

0.00

5.3

3.6

0.00

estimate

—

(3020682) Albumin/Creatinine [Ratio] in Urine

214

1.04

0.00

3.1

3.9

5.09

16.25

mg/mmol

1.30

130

(3013512) EKG study

181

0.99

0.00

4.8

3.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.0

2.6

—

467.56

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

0.00

0.0

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

0.89

0.00

1.2

2.4

1.35

1.99

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

0.90

0.00

1.4

4.5

1.19

1.22

mmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.9

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

0.00

0.0

1.7

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.6

—

68.44

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.6

—

34.00

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

8.18

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

1242.14

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.8

—

(3002256) Pathology report gross observation

0.99

-0.00

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

1.56

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

12.88

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

0.00

-0.00

0.0

1.6

—

0.14

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.12

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.6

—

(3010813) Leukocytes [#/volume] in Blood

829

1.02

-0.00

25.1

18.6

7.37

6.63

e9/l

2.45

807

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

2.80

—

(44813793) Dust mix specific IgE antibody measurement

0.00

-0.00

0.0

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

-0.00

0.0

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_ACCIDENTAL_POISO_EXPOS_ORGANIC_SOLVE_HALOGENA_HYDROCA_THEIR_VAPOU – Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours (VWXY20_ACCIDENTAL_POISO_EXPOS_ORGANIC_SOLVE_HALOGENA_HYDROCA_THEIR_VAPOU)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints